ArticleScientific reports2025
Clinical characteristics of hypertrophic olivary degeneration following brainstem or cerebellar hemorrhage.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hypertrophic Olivary Degeneration Following Brainstem Hemorrhage in a Patient with Tremor: A Case Report with Serial MRI Follow-Up.Journal of clinical medicine · 2026Article
- Effective radiofrequency thalamotomy for posttraumatic Holmes tremor: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Hypertrophic olivary degeneration mimicking tumor recurrence after brainstem radiosurgery: A diagnostic pitfall in neuro-oncology.Surgical neurology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Patients who have experienced bleeding in the posterior circulation of the brain often develop Hypertrophic Olivary Degeneration (HOD). This condition can lead to new neurological problems several months after the initial hemorrhage, potentially worsening the overall outcome for these patients. However, its pathogenesis and prognosis remain inconclusive. The research included 214 patients diagnosed with brainstem or cerebellar hemorrhage, of which 36 developed secondary HOD. The study aimed to analyze the clinical data of these patients, investigate the risk factors associated with HOD development, and evaluate the prognosis for those affected. (1) No significant differences in common cerebrovascular risk factors, such as hypertension and diabetes, were observed between the HOD and non-HOD groups among patients with lesions involving the Guillain-Mollaret triangle (GMT) (P > 0.05). (2) The site of hemorrhage was significantly correlated with the location of HOD (P < 0.05). (3) A significant association was found between the primary lesion's site and the interval before HOD onset (P < 0.05). (4) Patients in the HOD group showed poorer functional outcomes, reflected by higher mRS scores (Z = -2.859, P = 0.004) and lower ADL scores (Z = -2.859, P = 0.004). Among patients with brainstem or cerebellar hemorrhage, all individuals with HOD had lesions involving the GMT. A significant correlation was identified between the site of hemorrhage and the location of HOD. Cerebellar hemorrhage cases were associated with shorter intervals before HOD onset, and HOD was linked to significantly worse functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.